Selective FcγR Co-engagement on APCs Modulates the Activity of Therapeutic Antibodies Targeting T Cell Antigens.

MLA

Waight, Jeremy D., et al. “Selective FcγR Co-Engagement on APCs Modulates the Activity of Therapeutic Antibodies Targeting T Cell Antigens.” Cancer Cell, vol. 33, no. 6, June 2018, p. 1033. EBSCOhost, https://doi.org/10.1016/j.ccell.2018.05.005.

APA

Waight, J. D., Chand, D., Dietrich, S., Gombos, R., Horn, T., Gonzalez, A. M., Manrique, M., Swiech, L., Morin, B., Brittsan, C., Tanne, A., Akpeng, B., Croker, B. A., Buell, J. S., Stein, R., Savitsky, D. A., & Wilson, N. S. (2018). Selective FcγR Co-engagement on APCs Modulates the Activity of Therapeutic Antibodies Targeting T Cell Antigens. Cancer Cell, 33(6), 1033. https://doi.org/10.1016/j.ccell.2018.05.005

Chicago

Waight, Jeremy D, Dhan Chand, Sylvia Dietrich, Randi Gombos, Thomas Horn, Ana M Gonzalez, Mariana Manrique, et al. 2018. “Selective FcγR Co-Engagement on APCs Modulates the Activity of Therapeutic Antibodies Targeting T Cell Antigens.” Cancer Cell 33 (6): 1033. doi:10.1016/j.ccell.2018.05.005.